Evidence map›Paper›PMID 34363731›Full record

ArticleJournal of cosmetic dermatology2021

Pityriasis rosea following SARS-CoV-2 vaccination: A case series.

Selami Aykut Temiz, Ayman Abdelmaksoud, Recep Dursun, Koray Durmaz, Roxanna Sadoughifar, Abdulkarim Hasan

Abstract readLetter
In one paragraph

Article in Journal of cosmetic dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. SARS-CoV-2 vaccine-associated-tinnitus: A review.Annals of medicine and surgery (2012) · 2022
    Review
  13. Article
  14. Article
  15. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Selami Aykut TemizDepartment of Dermatology, Konya Ereğli State Hospital, Konya, Turkey.ORCID https://orcid.org/0000-0003-4878-0045
Ayman AbdelmaksoudMansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.ORCID https://orcid.org/0000-0003-4848-959X
Recep DursunDepartment of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
Koray DurmazDepartment of Dermatology, Bozüyük State Hospital, Bilecik, Turkey.ORCID https://orcid.org/0000-0002-8636-9866
Roxanna SadoughifarDepartment of Dermatology, University of Rome G. Marconi, Rome, Italy.
Abdulkarim HasanDepartment of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.ORCID https://orcid.org/0000-0003-0391-306X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Pityriasis RoseaCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19pityriasis roseavaccine

Identifiers

PMID34363731
PMCPMC8447003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.